Gender Differences in Achieving Optimal Lipid Goals in Patients With Coronary Artery Disease

被引:52
|
作者
Victor, Brett M. [1 ,2 ]
Teal, Valerie [3 ]
Ahedor, Lilian [4 ,5 ]
Karalis, Dean G. [1 ,2 ]
机构
[1] Univ Penn Hlth Syst, Penn Hosp, Dept Med, Philadelphia, PA 19104 USA
[2] Univ Penn Hlth Syst, Penn Hosp, Dept Cardiol, Philadelphia, PA USA
[3] Univ Penn, Biostat Anal Ctr, Philadelphia, PA 19104 USA
[4] Northwestern Lake Forest Hosp, Dept Med, Lake Forest, IL USA
[5] Northwestern Lake Forest Hosp, Dept Cardiol, Lake Forest, IL USA
来源
AMERICAN JOURNAL OF CARDIOLOGY | 2014年 / 113卷 / 10期
关键词
STATIN THERAPY; PREVENTION; WOMEN; DISPARITIES; PREDICTORS; PHYSICIAN; RISK; CARE;
D O I
10.1016/j.amjcard.2014.02.018
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To investigate gender differences in lipid goal attainment, we conducted a retrospective analysis of outpatient electronic health records from a large cardiology practice from September 2008 to September 2009. The most recent lipid profile and lipid-lowering medications and doses were extracted from electronic medical record. We identified 9,950 patients with coronary artery disease of whom 3,366 (34%) were women. Women were less likely to achieve a low-density lipoprotein (LDL) cholesterol goal of <70 mg/dl compared with men (30.6% vs 38.4%, p <0.001) and less likely to achieve a non high-density lipoprotein cholesterol goal of <100 mg/dl (37.1% vs 48.2%, p <0.001). Irrespective of age, women were less likely to achieve their LDL cholesterol goals. Compared with men, women were more likely to be on no statin (16.9% vs 11.6%, p <0.001) or any lipid-lowering therapy (12.8% vs 7.8%, p <0.001) and less likely to be on high-potency statin (14.9% vs 18.0%, p <0.001) or combination therapy (22.2% vs 30.1%, p <0.001). There exists a major difference in the use of lipid-lowering therapy between men and women with coronary artery disease. In conclusion, women with coronary artery disease are prescribed insufficient doses of statins and combination lipid-lowering therapy and are less likely to achieve their optimal LDL and non high-density lipoprotein cholesterol goals. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:1611 / 1615
页数:5
相关论文
共 50 条
  • [1] Achieving Optimal Lipid Goals in Patients With Coronary Artery Disease
    Karalis, Dean G.
    Subramanya, Raghunandan Dudda
    Hessen, Scott E.
    Liu, Longjian
    Victor, Mark F.
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2011, 107 (06): : 886 - 890
  • [2] Achieving blood lipid goals in patients with coronary artery disease
    McKenney, JM
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2001, 58 (05) : 415 - 419
  • [3] ACHIEVING OPTIMAL LIPID LEVELS IN PATIENTS WITH CORONARY ARTERY DISEASE IN CLINICAL PRACTICE
    Subramanya, Raghunandan Dudda
    Hessen, Scott E.
    Liu, Longjan
    Victor, Mark F.
    Karalis, Dean G.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (10)
  • [4] Use of Lipid-Lowering Medications and the Likelihood of Achieving Optimal LDL-Cholesterol Goals in Coronary Artery Disease Patients
    Karalis, Dean G.
    Victor, Brett
    Ahedor, Lilian
    Liu, Longjian
    [J]. CHOLESTEROL, 2012,
  • [5] Gender Disparities In Optimal Lipid Control Among Patients with Coronary Artery Disease
    Chen, Chun-Yen
    Chuang, Shao-Yuan
    Fang, Ching-Chang
    Huang, Lien-Chi
    Hsieh, I-Chang
    Pan, Wen-Harn
    Yeh, Hung-I
    Wu, Chau-Chung
    Yin, Wei-Hsien
    Chen, Jaw-Wen
    [J]. JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2014, 21 : S20 - S28
  • [6] Optimal goals for statin use in patients with coronary artery disease
    Ray, KK
    Cannon, CP
    [J]. CURRENT OPINION IN CARDIOLOGY, 2005, 20 (06) : 525 - 529
  • [7] Comorbidities in patients with coronary artery disease: gender differences
    Sumin, A. Alexey
    Korok, E. V.
    Shcheglova, A. V.
    Barbarash, O. L.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 102 - 102
  • [8] Gender differences in hemorheological parameters of coronary artery disease patients
    Bogar, L.
    Juricskay, I.
    Kesmarky, G.
    Feher, G.
    Kenyeres, P.
    Toth, K.
    [J]. CLINICAL HEMORHEOLOGY AND MICROCIRCULATION, 2006, 35 (1-2) : 99 - 103
  • [9] GENDER DIFFERENCES OF ASPIRIN RESISTANCE IN PATIENTS WITH CORONARY ARTERY DISEASE
    Jiang Zhi-Li
    Li Yan-Fang
    [J]. HEART, 2012, 98 : E200 - E200
  • [10] Gender Differences in the Rates of Screening and Achievement of Treatment Goals in Patients With Rheumatoid Arthritis and Coronary Artery Disease.
    Russell, Cori E.
    Denduluri, Srinivas
    Scherrer-Crosbie, Marielle
    [J]. CIRCULATION, 2018, 138